12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Sorrento deal

Sorrento said it acquired rights to patents covering the use of antibodies to produce recombinant IV immunoglobins (rIVIGs) from...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >